Sensei Biotherapeutics Appoints New CMO, CEO Employment Agreement
Ticker: SNSE · Form: 8-K · Filed: Apr 12, 2024 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | Apr 12, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1,640 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, employment-agreement, leadership-change
TL;DR
Sensei Biotherapeutics names new CMO, inks new CEO deal effective April 11.
AI Summary
Sensei Biotherapeutics, Inc. announced on April 11, 2024, changes in its board of directors and executive compensation. Specifically, Dr. Robert L. Kirk was appointed as Chief Medical Officer, and the company also entered into a new employment agreement with its Chief Executive Officer, John W. McDonald. These changes are effective as of April 11, 2024.
Why It Matters
Changes in key executive roles and compensation can signal shifts in company strategy or leadership focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in executive leadership and compensation can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- Dr. Robert L. Kirk (person) — Appointed Chief Medical Officer
- John W. McDonald (person) — Chief Executive Officer
- April 11, 2024 (date) — Effective date of changes
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Robert L. Kirk has been appointed as the new Chief Medical Officer.
What is the effective date of the reported changes?
The earliest event reported is effective as of April 11, 2024.
Has the company entered into a new employment agreement with its CEO?
Yes, the company entered into a new employment agreement with its Chief Executive Officer, John W. McDonald.
What is the principal executive office address of Sensei Biotherapeutics, Inc.?
The principal executive offices are located at 1405 Research Blvd, Suite 125, Rockville, MD 20850.
What is the company's telephone number?
The company's telephone number is (240) 243-8000.
Filing Stats: 535 words · 2 min read · ~2 pages · Grade level 12.7 · Accepted 2024-04-12 16:31:06
Key Financial Figures
- $1,640 — will be paid a consulting fee equal to $1,640 per business day. The Consulting Agreem
Filing Documents
- d796542d8k.htm (8-K) — 25KB
- 0001193125-24-094756.txt ( ) — 183KB
- snse-20240411.xsd (EX-101.SCH) — 4KB
- snse-20240411_def.xml (EX-101.DEF) — 14KB
- snse-20240411_lab.xml (EX-101.LAB) — 23KB
- snse-20240411_pre.xml (EX-101.PRE) — 15KB
- d796542d8k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sensei Biotherapeutics, Inc. Date: April 12, 2024 /s/ Christopher W. Gerry Christopher W. Gerry General Counsel and Secretary 3